
|Videos|April 15, 2016
Michelle Cheung from Queen Mary University of London: Studying Decompensated Cirrhosis Patients After HCV Treatment
Author(s)Caitlyn Fitzpatrick
A recent study in the United Kingdom looked at the 6-month outcomes of those with hepatitis C cirrhosis on antiviral treatment.
Advertisement
A recent study in the United Kingdom looked at the 6-month outcomes of those with hepatitis C cirrhosis on antiviral treatment.
Michelle Cheung, BSc, MBBS, from Queen Mary University of London, discussed the results of this research during the International Liver Congress (EASL 2016) in Barcelona, Spain. As hepatitis C becomes treatable, and even curable in many cases, doctors must still find ways to treat these patients and any potential comorbidities they may develop during their treatment process.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
5


























































